Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
INCY
INCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INCY News
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
Jun 26 2026
NASDAQ.COM
Incyte Breaks Out of Seven-Month Range
Jun 26 2026
CNBC
US Stock Market Under Pressure as Chip Stocks Plummet
Jun 26 2026
NASDAQ.COM
EU Drug Regulator Endorses Six New Medicines for Approval
Jun 26 2026
seekingalpha
ON Semiconductor Shares Plunge 19.9% Despite Year-to-Date Gain of 75.6%
Jun 26 2026
NASDAQ.COM
Star Therapeutics Announces VGA039 Study Data Presentation at ISTH 2026
Jun 26 2026
Newsfilter
Opzelura Receives Positive CHMP Opinion for Moderate Atopic Dermatitis Treatment
Jun 26 2026
Newsfilter
Mixed Market Close: Tech Stocks Decline Amid Leadership Changes
Jun 22 2026
NASDAQ.COM
Incyte's Minjuvi Approved in Japan for DLBCL Treatment
Jun 19 2026
NASDAQ.COM
Zacks Premium Empowers Investors with Confidence and Insights
Jun 19 2026
NASDAQ.COM
Japan Approves Minjuvi for Lymphoma Treatment
Jun 19 2026
Newsfilter
Mirum and Incyte Report Positive Results for FOP Study
Jun 17 2026
NASDAQ.COM
Mirum and Incyte Report Positive Phase 2 Data for Zilurgisertib
Jun 15 2026
seekingalpha
Mirum and Incyte Announce New Progress in FOP Treatment
Jun 14 2026
Yahoo Finance
Mirum and Incyte Announce FOP Study Results
Jun 14 2026
Newsfilter
INCA033989 Shows Promising Clinical Benefits in Myelofibrosis and Essential Thrombocythemia
Jun 13 2026
Newsfilter
Show More News
